Skip to main content
Premium Trial:

Request an Annual Quote

Court Bars Bio-Rad, MJ Research from Selling PCR Thermal Cyclers That Infringe Applera s Patents in US

NEW YORK, Sept. 2 (GenomeWeb News) - A US court has barred Bio-Rad Laboratories and MJ Research from making or selling PCR thermal cyclers that infringe patents held by Applera, Applied Biosystems said yesterday.


Through its injunction, the US District Court for the District of Connecticut in New Haven also prohibits Bio-Rad and MJ Research, which is owned by Bio-Rad, from servicing, repairing, advertising, instructing, or otherwise promoting the use of infringing thermal cyclers for use with PCR.


The court's decision is based on an earlier jury verdict showing that the companies infringe US Patents No. 5,333,675; No. 5,656,493; and No. 5,475,610.


In April, the New Haven court increased damages awarded to ABI and Roche in their PCR patent-infringement suit against MJ Research and company founders Michael and John Finney, which include these patents, to approximately $35.4 million plus attorneys' fees. A jury one year earlier awarded the companies $19.8 million in damages.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.